Get early access! Join the Twelve Data AI Assistant waitlist now.

ALGS

10.20000 USD
0.36
3.66%
Last update Aug 22, 3:57 PM EDT
Market closed
Day range
9.38830
10.83310
Previous close
9.84000
Open
9.88000
Access this stock data via API
Subscribe
Aligos Therapeutics, Inc.
10.20
0.36
3.66%

Financials

Income statement

Fiscal date Jun 2025 Mar 2025 Dec 2024 Sep 2024
Total reported revenue 965K 311K 629K 1.3M
Cost of revenue
Gross profit
Operating expense
Research & development 14.0M 14.5M 16.0M 16.8M
Selling general and admin 5.6M 5.1M 5.2M 4.6M
Other operating expenses
Operating income -18.6M -19.2M -20.6M -20.1M
Non operating interest income
Income 396K 842K 457K
Expense
Other income expense 2.5M 61.5M -64.6M 506K
Pretax income -15.7M 43.1M -82.1M -19.2M
Tax provision 185K 43K 27K 91K
Net income -15.9M 43.1M -82.2M -19.3M
Basic EPS -1.5 5.1 -13.1 -3.1
Diluted EPS -1.5 -2.1 -13.1 -3.1
Basic average shares 10.4M 8.4M 6.3M 6.3M
Diluted average shares 10.4M 8.7M 6.3M 6.3M
EBITDA -19.4M -80.2M -19.9M -19.5M
Net income from continuing op. -15.9M 43.1M -82.2M -19.3M
Minority interests
Preferred stock dividends
Market closed

Exchange is currently closed
Pre-market opens in 2 days 4 hours 45 minutes

23:14
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).